Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management
Open Access
- 18 March 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (20), 1306-1315
- https://doi.org/10.1093/eurheartj/ehu100
Abstract
Several drugs used in the treatment of mental diseases are associated with an increased risk of sudden cardiac death (SCD). A general cause-relationship between the intake of these drugs and SCD is unattainable, but numerous case reports of drug-induced malignant arrhythmia and epidemiological studies, associating the use of specific drugs with SCD, strongly support the presence of an increased risk. Whereas the absolute risk of drug-induced life-threatening arrhythmia may be relatively low, even small increments in risk of SCD may have a major health impact considering that millions of patients are treated with psychotropics. In subgroups of pre-disposed patients, e.g. patients with cardiac diseases or other co-morbidities, the elderly or patients treated with other negatively interacting drugs, the absolute risk of drug-induced arrhythmia may be considerable. On the other hand, several of the major mental disorders are associated with a large risk of suicide if untreated. The observed risk of malignant arrhythmia associated with treatment with psychotropic drugs calls for clinical guidelines integrating the risk of the individual drug and other potentially interacting risk factors. In this review, data from various authorities on the risk of arrhythmia associated with psychotropic medications were weighted and categorized into three risk categories. Additionally, we suggest a clinically applicable algorithm to reduce the risk of malignant arrhythmia in patients to be treated with psychotropic medications. The algorithm integrates the risk categories of the individual drugs and pre-disposing risk factors and suggests a prudent follow-up for patients with an increased risk. We believe this clinically manageable guideline might improve safety in the many and rapidly increasing number of patients on psychotropic drugs.Keywords
This publication has 92 references indexed in Scilit:
- Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical TrialsJAMA Psychiatry, 2013
- Antidepressant Use and Risk of Out-of-Hospital Cardiac Arrest: A Nationwide Case–Time–Control StudyCancer Cell, 2012
- Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac deathHeart, 2010
- Cardiovascular risk in patients with bipolar disorderJournal of Affective Disorders, 2009
- Depression and Risk of Sudden Cardiac Death and Coronary Heart Disease in WomenJournal of the American College of Cardiology, 2009
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Clinical Depression and Risk of Out-of-Hospital Cardiac ArrestArchives of Internal Medicine, 2006
- Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic MedicationsNew England Journal of Medicine, 2005
- Causes of the excess mortality of schizophreniaThe British Journal of Psychiatry, 2000
- Cardiovascular death and manic-depressive psychosisJournal of Affective Disorders, 1987